The duality of the Foxglove is a lesson in tipping points. It is an important medicine.​ Its duality is due to its narrow therapeutic window: give too little and it does not work.​ Give too much and it is toxic.

Foxglove was established in 2021 with the mission of incubating scalable solutions to existential problems. Headquartered in Australia but globally networked, we focus on supporting the best entrepreneurs in the critical sectors of carbon sequestration, energy transition and security. 

Our capital allocation decisions are guided by a deep conviction in our investment thematics, of where capital flows must be reallocated to over the coming decades. We work inside and alongside our portfolio companies to lower risk and seize opportunities and shepherd them to the point at which they are ready for institutional investors.